Centre de documentació: resultats de cerca

Exploring Beneath the Wave Surface: EEGs in DEEs.
Autor/s:
Hartman AL.
Editorial
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218091
Seeing Less, Predicting More: CT or MRI in People With Covert Cerebrovascular Disease.
Autor/s:
Tourdias T.
Editorial
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218167
Sometimes Kids Really Are Just Little Adults: Early Access to High-Efficacy Therapy Decreases Disability in Pediatric Multiple Sclerosis.
Autor/s:
Gombolay GY, Rubin JP.
Editorial
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218168
Should Levetiracetam Be the Automatic First-Line Choice in Pediatric Epilepsy?
Autor/s:
Matsumoto JH.
Editorial
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218170
Early-Onset Stroke Genetics: Why Age- and Ancestry-Specific Genetic Architecture Matters.
Autor/s:
Lee KJ, Choi JC.
Editorial
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218208
Article
A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy.
Autor/s:
McDonald CM, Signorovitch J, Goemans NM, Mercuri E, Gordish-Dressman H, Vandenborne K, Sajeev G, Ward SJ, Fillbrunn M, Frean M, Servais L, Niks EH, Straub V, De Groot IJM, Muntoni F; iMDEX, for the PRO-DMD-01 Study, ImagingDMD, CINRG DNHS, and Universitaire Ziekenhuizen Leuven Group.
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000214705
Article
Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies: Phenotype, Genotype, and Outcome.
Autor/s:
Riccardi F, Desnous B, Borloz E, Lepine A, Lacoste C, Mignon-Ravix C, Cacciagli P, Missirian C, Molinari F, Mortreux J, Afenjar A, Altuzarra C, Auvin S, Bar C, Barth M, Biscaye S, Bourel-Ponchel E, Cabasson S, Cances C, Castelnau P, Caubel I, Carneiro M, Chabrol B, Chadie A, Chaussenot A, Cheuret E...
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218013
Article
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.
Autor/s:
Sharmin S, Roos I, Labauge PM, Filippi M, Lebrun-Frenay C, Iaffaldano P, Simone M, Perini P, Magy L, Van Der Walt A, Butzkueven H, Manchon E, Alroughani R, Patti F, Pozzilli C, Eichau S, Morra VB, Laplaud DA, Maimone D, Portaccio E, Trojano M, Amato MP, Deiva K, Vukusic S, Kalincik T; MSBase, OFSEP...
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218056
Article
Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder.
Autor/s:
Pacoureau L, Bicart-Sée L, Morgane LG, Viala K, Maisonobe T, Beaudonnet G, Adam C, Vicino A, Théaudin M, Boutboul D, Roos-Weil D, Camdessanche JP, Pereon Y, Dormeuil A, Lipsker D, Acket B, Svahn J, Cluse F, Pegat A, Urbain F, Lambotte O, Labeyrie C, Noël N.
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218057
Article
Diagnostic Agreement and Prognostic Value of Clinically Interpreted CT vs MRI for Incidentally Discovered Covert Cerebrovascular Disease.
Autor/s:
Kent DM, Puttock EJ, Leung LY, Sangha NS, Madan N, Smith EE, Nguyen-Huynh MN, Chen W.
Any publicació:
2026
Número de revista:
Neurology vol. 106 n. 12
https://www.neurology.org/doi/full/10.1212/WNL.0000000000218058

Una iniciativa de:

Cercador

Exploring Beneath the Wave Surface: EEGs in DEEs.

Seeing Less, Predicting More: CT or MRI in People With Covert Cerebrovascular Disease.

Sometimes Kids Really Are Just Little Adults: Early Access to High-Efficacy Therapy Decreases Disability in Pediatric Multiple Sclerosis.

Should Levetiracetam Be the Automatic First-Line Choice in Pediatric Epilepsy?

Early-Onset Stroke Genetics: Why Age- and Ancestry-Specific Genetic Architecture Matters.

A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy.

Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies: Phenotype, Genotype, and Outcome.

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder.

Diagnostic Agreement and Prognostic Value of Clinically Interpreted CT vs MRI for Incidentally Discovered Covert Cerebrovascular Disease.

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!